Trials / Enrolling By Invitation
Enrolling By InvitationNCT07118189
Laying the Foundation for Building a Resilient KPNC Community in the Face of Worsening Air Quality Due to Wildfire Smoke
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Kaiser Permanente · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The overarching goal of this project is to conduct a pilot intervention in high-risk Kaiser Permanente Northern California patients with chronic obstructive pulmonary disease to mitigate their exposure to poor air quality and decrease exacerbations of lung disease.
Detailed description
Over the past decade, the frequency and impact of wildfires has steadily worsened across California, a trend that is expected to continue as climate change becomes an urgent, everyday reality. This means that the number of Kaiser Permanente Northern California (KPNC) members exposed to unhealthy air quality due to wildfire smoke will increase dramatically. Unsurprisingly, vulnerable patients are disproportionately impacted, such as those with chronic obstructive pulmonary disease (COPD). In this rigorous pilot, we will deploy a pilot in-home intervention to non-smoking, oxygen-dependent patients who have frequent exacerbations of COPD to mitigate their exposure to poor air quality and reduce exacerbations.
Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Exacerbation of COPD
- Exacerbation of Chronic Obstructive Pulmonary Disease
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | N95 masks and indoor air cleaner | Participants who are randomized into the intervention will receive N95 masks to be worn outdoors and an indoor air cleaner in the room that the participant spends the most time in their home. Both intervention and control arms will receive education. |
Timeline
- Start date
- 2025-10-07
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2025-08-12
- Last updated
- 2025-11-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07118189. Inclusion in this directory is not an endorsement.